Immediate-Use Compounding Still Tripping Up Health Systems During Joint Commission Surveys

Immediate-use compounding continues to be one of the most common pain points during Joint Commission surveys, according to new data the group presented at the ASHP Pharmacy Futures 2025 meeting, in Charlotte, North Carolina.